CLINICAL_TRIALS
trial_result
· 2022-07-05
Clinical Trial Update: The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma [Phase 2]
Summary
Phase 2 trial evaluating 18F-DOPA-PET utility in treating recurrent high-grade glioma completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Glioma | Phase 2 | Status: COMPLETED | Results posted: 2022-07-05